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Supplemental Experimental Procedures:
Mouse lines: All animal experiments were performed according to the German animal welfare law for animal experimentation. Mutant mice were bred and maintained on a C57BL/6 background. The generation of CNP-Cre mice (Lappe-Siefke et al., 2003) , and cofilin1fl/fl mice (Bellenchi et al., 2007 , Flynn et al., 2012 has been described previously. To generate oligodendrocyte-specific ADF-/-/cofilin1 knock-out mice, CNP-Cre mice were crossbred with cofilin1fl/fl and crossed with ADF-/-to generate ADF-/-; cofilin1fl/fl; CNP-Cre+/-.
Shiverer mice lacking MBP were maintained on a C57BL/6 background. 
Reagents

Glial cell preparation:
Primary cell cultures were prepared as described previously (Trajkovic et al., 2006) . All basal media, supplements, antibiotics, and sera were purchased from Gibco/Invitrogen (Invitrogen, Darmstadt, Germany) Briefly, brains were extracted from P1 NMRI mice. After treatment with 0.25 % trypsin-EDTA for 10 min, cells were dissociated and seeded into poly-L-lysine (PLL) coated cell culture flasks. Primary glial mixed cultures were grown in Basal Medium Eagle supplemented with 10% horse, 1% GlutaMax, and 1% penicillin/streptomycin. After 7-8 days, primary oligodendrocyte progenitor cells (OPCs) were manually shaken off the mixed glial culture and plated onto PLL coated coverslips. OPCs were kept in a humidified 37°C
incubator, supplemented with 7.5% CO 2 in differentiation medium. For in vitro treatment of oligodendrocytes, all compounds were dissolved in DMSO. In order to minimize the effects of the vehicle on the cells, the concentration of the stock solution allowed a dilution to the working solution by the factor of 1:1000. Cells were 8 incubated at 37°C for 8 h followed by fixation applying a 4 % PFA/0.15 % glutaraldehyde mixture. For controls, the exact same volume of the drug's vehicle was used. System was used to detect APP and GFAP, and the Vector Elite System was used to detect MAC3. Per marker and mouse, one histological section comprising both fimbriae were analyzed and the mean of both fimbriae was used for statistical assessment using one-way ANOVA with Tukey's post-test in Graphpad Prism 6.0.
Immunocytochemistry and immunohistochemtistry:
Immunoelectron microscopy: Tokuyasu sections was performed as described in Peters and Pierson (2008) using antibodies directed against CNP. The monoclonal antibodies were detected with protein A gold (10nm) after incubation with a bridging antibody raised in rabbit.
Molecular Cloning:
The cDNA encoding recombinant full-length CNP (rmCNP) was used as template for polymerase chain reaction with the forward (5'-GGCGGCGGATCCAAGATGtcatcctcaggagcaaagg-3') and reverse (5'-TCCTCCGAATTCgatgatggtgcagatctgcatg-3') oligonucleotide primers. Modified and amplified PCR products were sub-cloned into the mammalian expression vector pcDNA3.1(+) (Invitrogen, Darmstadt, Germany). C-terminal or N-terminal insertion of the lipid-binding region R1-3 of NHE3 (sodium-hydrogen exchanger 3) (Alexander et al., 2011) , was performed by the annealing of the overlapping single stranded oligonucleotides and ligation into the site of interest. Standard methods of molecular cloning like restriction digestion, ligation and transformation (via heat shock) into chemically competent E. coli DH5α competent were utilized. DNA screening by restriction digestion was followed by automated DNA sequencing (DNA Core 9 Facility, Max Planck Institute of Experimental Medicine, Göttingen, Germany). Confirmed clones with a correct DNA sequence were used for a medium scale DNA preparation.
Expression and purification of proteins:
The large-scale expression of recombinant GFP with N-terminal insertion of the lipid-binding region R1-3 of NHE3 (GFP-R3) and CNP with C-terminal insertion (CNP-R3) and of the 14kDa-isoform of recombinant MBP (rmMBP) was performed as previously described (Aggarwal et al., 2011) . Plasmids were transformed into E. coli strain TOP10F' (Thermo Fisher Scientific) and grown at 25°C
until an optical density at 600 nm (OD 600 ) of 3.0 in TB medium supplemented with 50 mg/ml kanamycin).
Cultures were induced with 0.15 mM isopropyl β-D-1-thiogalactopyranoside (IPTG), warmed to 37°C and further shaken overnight. Prior cell harvesting, 1 mM phenylmethylsulfonylfluoride (PMSF) and 5 mM EDTA were added to the cultures. Cells were re-suspended in HS buffer (1.3 M NaCl, 220 mM Tris-HCl pH 7.5, 11
mM MgCl 2 , 10 mM imidazole, 2.2 mM EDTA, 10 mM DTT) and lysed by sonication followed by centrifugation for 1 h at 37,000 rpm. Cleared lysates were applied to a nickel-chelate matrix equilibrated with HS buffer. After washing with HS buffer and HNS buffer (20 mM HEPES, 100 mM NaCl, 250 mM sucrose, 5 mM DTT, final pH 7.3), bound proteins were eluted by incubation with SUMO protease (20 nM) for 15 min at RT. The 14-kDa isoform of MBP was expressed in E. coli strain BLR harboring the plasmid pRIL. Cells were cultured in TB medium containing 50 mg/ml kanamycin and 37 mg/ml chloramphenicol at 37°C to OD 600 = 6.0 followed by induction with 1 mM IPTG and shaken for 6 h at 37°C. Before harvesting, 1 mM PMSF and 5 mM EDTA were added to the cultures. Cells were then re-suspended in 8.3 M guanidine hydrochloride containing 2 mM EDTA and 20 mM DTT followed by lysis via freezing and thawing. Lysates were cleared by centrifugation at 37,000
rpm for 1 h and supplemented with 100 mM Tris-HCl pH 8.5 and 1 mM imidazole and applied to a nickelchelate column. The column was washed with 7.5 mM guanidine hydrochloride, 100 mM Tris-HCl pH 8.5, 1 mM EDTA, and 1 mM imidazole followed by a second washing step with 8 M urea, 20 mM Tris-Hcl pH 8.0, 1 mM EDTA, and 1 mM imidazole. Bound protein was eluted by application of the same buffer supplemented with 500 mM imidazole, diluted 1:3 with water and applied to a thiopyridine-activated SH-reactive matrix. The matrix was washed with 6 M guanidine hydrochloride, 20 mM Tris-HCl pH 8.0, and 1 mM EDTA, 1 mM imidazole, and eluted with 6 M guanidine hydrochloride, 20 mM Tris-HCl pH 7.5, 10 mM DTT followed by application to preparative C18 reverse phase HPLC column, eluted with increasing concentrations of acetonitrile in 0.15% TFA, and lyophilized.
Biomimetic assay:
To mimic the inner leaflet composition of myelin (Inouye and Kirschner, 1988) , the mole% of 44% cholesterol, 27% phosphatidylethanolamine (PE), 2% phosphatidylinositol-4,5-bisphosphate (PIP2), 11.5% phosphatidylcholine (PC), 12.5% phosphatidylserine (PS), 3% sphingomyelin (SM) lipid mixture was used at a final concentration of 1 mg/ml. The preparation of supported lipid bilayers (SLBs), lipids were diluted in chloroform in the appropriate concentration and dried in a vacuum concentrator (Concentrator plus, Eppendorf AG, Hamburg) at 30°C for 1.5 h followed by hydration in 50 mM HEPES containing 100 mM NaCl (pH 7.4).
Then, the lipid mixture was sonicated for 30 min at 70°C and 50 % power in an ultrasonic bath (Sonorex Super 10 P, Sigma-Aldrich). To generate small unilamellar vesicles (SUVs), the lipid mixture was further treated by tip sonication at 40% (Sonoplus, Bandelin, Berlin) for 10 to 20 min until a clear solution was obtained. Until usage, SUVs were stored at 4°C for maximum seven days. For the subsequent visualization of the SLBs, the lipid mixture was substituted with TopFluor® Lyso PC (Avanti Lipid Polar, Inc., Alabaster, Alabama, USA). SUVs were spread onto the cleaned and hydrated 18 mm coverslips and incubated for 1h at RT in a dark chamber to protect them from light. To allow the final spreading of the vesicles, coverslips were further incubated for 15 min at 37°C. The unbound lipids were removed by washing three times with 50 mM HEPES, consecutively.
Next, the incorporation of recombinant proteins was performed at RT by the dilution of proteins to the appropriate concentration and buffer conditions to allow their binding onto the membrane, followed by intense washing to remove unbound proteins. For the incorporation of actin into the SLBs non-muscle actin, purified from human platelets was purchased (Cytoskeleton, Inch., Denver, USA, Distributor: BIOMOL GmbH, Hamburg, Germany). While binding to the SLBs, actin was polymerized to filamentous actin (F-actin).
Therefore, globular actin (G-actin) was polymerized at 5 µM concentration in 1 x F-Buffer containing: 10 mM Tris-HCl, 50 mM KCl, 2 mM MgCl 2 , 5 mM guanidine carbonate, and 1 mM ATP (pH 7.5) and incubated overnight on glass coverslips containing SLBs to allow its polymerization and binding to the negatively charged bilayer at the same time. After the overnight incubation, coverslips were intensively rinsed with 1 x F-Buffer, followed by incorporation of MBP or direct performance of the GUV bursting assay. In the presence of F-actin the polymerizing conditions were kept throughout the course of the experiment.
For the preparation of giant unilamellar vesicles (GUVs), the lipids PC and PS were mixed in chloroform in a 2:1 molar ratio, followed by drying on a vacuum concentrator and hydration in chloroform. An electroformation method was used to generate GUVs. Therefore, the mixture composed of two lipids was spread on the electrically conductive side of glass slides coated with indium-tin oxide (ITO). Slides were allowed to dry 11 overnight at 37°C. Visualization of GUVs was enabled by their fluorescent labelling using Texas Red DHPE (Invitrogen). GUVs were grown in the perfusion chamber in the presence of 0.1 M sucrose/water solution as a result of lipid swelling under an alternating current field (Garcia-Saez et al.; Kahya et al., 2005) . Obtained GUVs had a diameter ranging from 5 to 100 µm. Confocal imaging using a Zeiss Meta 510 microscope and live cell imaging dishes was performed to visualize the behavior of the GUVs upon attachment to the SLBs. To study the "bursting kinetics" of the vesicles, each experiment has been carried out for 30 min while one picture per minute was taken after addition of the GUVs.
Actin purification: Pig muscle actin was extracted and purified as described previously (Ignatev et al., 2012, Pardee and Spudich, 1982) . Monomeric actin was stored in dialysis against the gel filtration buffer ( F-actin co-sedimentation: Calmodulin (CaM) was purified as previously described (Kursula and Majava, 2007) . Different mutants of rmCNP were purified as described (Myllykoski et al., 2013) . The constructs used for co-sedimentation included full-length CNP, its N-and C-terminal domains, a catalytically inactive mutant of the C-terminal catalytic domain (H230Q/H309Q), and the catalytic domain extended at the C-terminus. Before the co-sedimentation assays, actin was further purified using size-exclusion chromatography. Purified G-actin was polymerized in F-buffer (5 mM Tris-HCl pH 7.8, 0.2 mM ATP, 0.1 mM CaCl 2 , 1 mM DTT, 100 mM KCl, 1 mM MgCl 2 ) for 45 min and incubated at 5 µM with CNP constructs, CaM, and S100β in different combinations for 45 min or 20 h at RT. The mixtures were centrifuged with a TLA-100 rotor at 100,000 rpm (approx. 436,000
x g) for 45 min at 20°C. The supernatant was removed, and the pellet was briefly washed and resuspended in the initial volume. Pellet and supernatant fractions were analyzed by SDS-PAGE.
Actin bundling: Muscle actin was polymerized at 5 µM concentration with 2 mM MgCl 2 and 100 mM KCl overnight in 500 µl. Proteins to be tested for binding were prepared first as 10 µM stocks in 1 x F-buffer with further dilution. Then, actin was diluted to 2.5 µM by adding 1 µM, 2.5 µM, and 5 µM of different CNP mutants plus 1 x F-buffer to a final volume 60 µl. Proteins were incubated in Eppendorf tubes for 1 h and spun at 21,000
x g for bundling assays. After centrifugation, the supernatants were transferred to Eppendorf tubes and 10 µl of 2x SDS sample buffer was added. Pellets were rinsed with 50 µl of 1 x F-buffer and resuspended in 20 µl of 1 x F-buffer plus 10 µl of 2x SDS sample buffer by extensive pipetting. 15 µl of each sample was taken for SDS-
PAGE.
Actin polymerization assay: Pyrene actin was obtained from muscle actin by labeling with pyrene (Cytoskeleton, Inc. Denver, USA). Muscle G-actin was taken to make a final concentration 3.9 µM from a 19 µM stock solution. Pyrene actin was added to a final concentration of 0.1 µM (2.5% of 4 µM total actin). Total reaction volume was 150 µl, half of which was a mixture of G-actin, pyrene actin, and G-buffer. The other half was 10x F-buffer, 4 µM of CNP plus G-buffer. The measurement was started immediately (with instrument initiation and 5 s shaking delay) after the two reaction halves were mixed, and continued for 1 h with 10 s frames. Measurements were done in duplicate.
Electron microscopy of CNP-microfilament complexes: Actin and His-tagged full-length CNP were mixed at 1 µM both in F-buffer. The samples were incubated for 17.5 h before grid preparation, and a 1:500 dilution of the mouse anti-His antibody was used. Thereafter, a gold-conjugated secondary antibody was used, and imaging was done using standard techniques on a Tecnai G2 Spirit 120 kV TEM instrument at the Biocenter Oulu EM Core Facility.
Covalent crosslinking and mass spectrometry: Freshly purified monomeric actin was polymerized by adding 50 mM KCl and 2 mM MgCl 2 to the existing buffer, and incubating overnight on ice. The polymerized protein had significantly increased viscosity, and F-actin was then harvested using ultracentrifugation. The F-actin pellet was dissolved in 1.5x crosslinking buffer (150 mM Bis-tris methane, 225 mM NaCl, 6 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 30 mM N-hydroxysuccinimide (NHS), pH 6.5) and used directly for crosslinking experiments. Protein crosslinking was carried out using EDC chemistry, where a protein with surface carboxyl groups is activated using EDC and stabilized using NHS. After this, the activation reaction is quenched with β-mercaptoethanol, and proteins with surface amino groups are added, which then react with the activated carboxyl groups to produce a zero spacer length peptide crosslink. The remaining activated groups can be back-reacted to free carboxyl groups by the addition of excess ethanolamine. All crosslinking reactions were carried out at 39.2 µM final protein concentration. To activate variants of rmCNP, the proteins were diluted using 1x crosslinking buffer (100 mM Bis-tris methane, 150 mM NaCl, 4 mM EDC, 20 mM NHS, pH 6.5). The
